Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,857 | 263 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $952.07 | 68 | $0 (2024) |
| ITI, Inc. | $736.15 | 56 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $517.45 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $319.15 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $301.41 | 19 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $283.76 | 27 | $0 (2024) |
| Alkermes, Inc. | $185.75 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $143.10 | 9 | $0 (2024) |
| Axsome Therapeutics, Inc. | $92.94 | 5 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $67.24 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $903.79 | 62 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($283.76) |
| 2023 | $1,167 | 92 | ITI, Inc. ($324.68) |
| 2022 | $1,078 | 65 | ABBVIE INC. ($394.41) |
| 2021 | $707.49 | 44 | AbbVie Inc. ($327.35) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: CNS | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Central Nervous System | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Neurology | ||||||
| 08/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Central Nervous System | ||||||
| 08/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Neuroscience | ||||||
| 07/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 8 | 726 | 1,226 | $130,243 | $71,989 |
| 2020 | 9 | 929 | 1,541 | $159,074 | $89,700 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 215 | 258 | $38,943 | $21,985 | 56.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 172 | 363 | $37,055 | $20,864 | 56.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 169 | 427 | $30,794 | $17,483 | 56.8% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 78 | 82 | $9,548 | $5,400 | 56.6% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 38 | 38 | $7,601 | $3,609 | 47.5% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 23 | 24 | $4,325 | $1,421 | 32.9% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2021 | 14 | 14 | $1,119 | $659.26 | 58.9% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 17 | 20 | $858.40 | $567.40 | 66.1% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 207 | 273 | $41,322 | $23,627 | 57.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 171 | 445 | $33,448 | $19,827 | 59.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 157 | 312 | $30,828 | $18,440 | 59.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 62 | 79 | $14,304 | $5,160 | 36.1% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2020 | 88 | 99 | $7,569 | $4,704 | 62.1% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 82 | 154 | $7,382 | $3,948 | 53.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 22 | 22 | $7,201 | $3,475 | 48.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 33 | 36 | $5,145 | $3,182 | 61.8% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 17 | 18 | $2,941 | $1,996 | 67.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2020 | 23 | 24 | $3,078 | $1,676 | 54.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 20 | 24 | $2,312 | $1,437 | 62.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 19 | 21 | $1,542 | $952.35 | 61.8% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2020 | 14 | 15 | $1,143 | $724.37 | 63.4% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 14 | 19 | $858.40 | $551.56 | 64.3% |
About Kimberly Schat, APRN-CNP, PMHNP-BC
Kimberly Schat, APRN-CNP, PMHNP-BC is a Nurse Practitioner healthcare provider based in Chickasha, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2017. The National Provider Identifier (NPI) number assigned to this provider is 1194250738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimberly Schat, APRN-CNP, PMHNP-BC has received a total of $3,857 in payments from pharmaceutical and medical device companies, with $903.79 received in 2024. These payments were reported across 263 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,857).
As a Medicare-enrolled provider, Schat has provided services to 1,655 Medicare beneficiaries, totaling 2,767 services with total Medicare billing of $161,689. Data is available for 2 years (2020–2021), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Chickasha, OK
- Active Since 04/20/2017
- Last Updated 06/02/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194250738
Products in Payments
- CAPLYTA (Drug) $1,020
- VRAYLAR (Drug) $952.07
- SPRAVATO (Drug) $299.19
- AUSTEDO (Drug) $281.34
- Austedo XR (Drug) $200.40
- ARISTADA (Drug) $185.75
- TRINTELLIX (Drug) $143.10
- ABILIFY MAINTENA (Drug) $128.10
- REXULTI (Drug) $113.74
- NUEDEXTA (Drug) $110.22
- Auvelity (Drug) $92.94
- FANAPT (Drug) $67.24
- Nuedexta (Drug) $47.37
- INGREZZA (Drug) $41.54
- UZEDY (Drug) $35.71
- BELSOMRA (Drug) $35.07
- LOREEV XR (Drug) $34.25
- INVEGA SUSTENNA (Drug) $19.96
- SERTRALINE HCL (Drug) $17.40
- QUVIVIQ (Drug) $16.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.